Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024)
Akari Therapeutics' (AKTX) quarterly Depreciation & Amortization (CF) came in at $1000.0 in Q4 2024, little changed year-on-year from $1000.0 in Q1 2024, and down 92.31% quarter-over-quarter from $13000.0 in Q1 2024.
Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024) Analysis & Trends
Akari Therapeutics has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $1000.0 for Q4 2024.
- Depreciation & Amortization (CF) for Q4 2024 came in at $1000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $1000.0 (down 92.86% YoY), and the FY2024 annual result was $14000.0, up 250.0% from the prior year.
- Depreciation & Amortization (CF) came in at $1000.0 for Q4 2024 at Akari Therapeutics, down from $13000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $13000.0 in Q1 2024 to a low of $986.0 in Q3 2020.
- The 3-year median for Depreciation & Amortization (CF) is $1000.0 (2020), against an average of $2690.7.
- Across the five-year window, Depreciation & Amortization (CF) plunged 78.69% in 2020 and soared 1200.0% in 2024, its largest moves.
- Akari Therapeutics' Depreciation & Amortization (CF) stood at $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
- The last three Depreciation & Amortization (CF) figures came in at $1000.0 (Q4 2024), $13000.0 (Q1 2024), and $1000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 123.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 986.00 |
| Sep 30, 2020 | 986.00 |
| Jun 30, 2020 | 3,044.00 |
| Jun 30, 2020 | 3,044.00 |
| Mar 31, 2020 | 3,877.00 |
| Mar 31, 2020 | 3,877.00 |